Adv Neonatal Care. 2021 Dec 01;21(6):452-461. doi: 10.1097/ANC.0000000000000959.
Vagal Tone and Proinflammatory Cytokines Predict Feeding Intolerance and Necrotizing Enterocolitis Risk.
Advances in neonatal care : official journal of the National Association of Neonatal Nurses
Alissa L Meister, Fumiyuki C Gardner, Kirsteen N Browning, R Alberto Travagli, Charles Palmer, Kim Kopenhaver Doheny
Affiliations
Affiliations
- Department of Neural and Behavioral Sciences (Drs Meister, Browning, Travagli, and Doheny), and Division of Neonatal-Perinatal Medicine, Department of Pediatrics (Drs Gardner, Palmer and Doheny), College of Medicine, The Pennsylvania State University, Hershey.
PMID: 34847103
PMCID: PMC8638911 DOI: 10.1097/ANC.0000000000000959
Abstract
BACKGROUND: Necrotizing enterocolitis (NEC) is the leading cause of death due to gastrointestinal disease in preterm neonates; yet, clinicians lack reliable and noninvasive predictive tools.
PURPOSE: We aimed to test that diminished high-frequency heart rate variability (HF-HRV) and elevated levels of proinflammatory cytokines would have utility in NEC prediction.
METHODS: In this multisite prospective study, we enrolled 250 preterm (26-34 weeks' postmenstrual age [PMA]) neonates with physiological stability at 72 hours of life. HRV was measured noninvasively using electrocardiograhic data from standardized cardiorespiratory monitors at postnatal week 1 of life and weekly thereafter until 35 weeks' PMA or discharge; blood was collected for cytokines at postnatal weeks 1 and 3. NEC was diagnosed via Modified Bell's Staging Criteria.
RESULTS: HF-HRV was decreased at weeks 1 and 2 in neonates (47% females) who developed feeding intolerance or stage 2+ NEC. In addition, these neonates displayed elevated levels of IL-8 at week 1 and increased levels of IL-1β, IL-6, TNF-α, and IL-8 at week 3 of life. Low HF-HRV was associated with elevated IL-6 or IL-8 levels at weeks 1 and 3 of life. Logistic regression indicated that only HF-HRV was a significant predictor of feeding intolerance or NEC development.
IMPLICATIONS FOR PRACTICE AND RESEARCH: HRV is a promising noninvasive modality for NEC risk detection. The association of low HF-HRV with elevated proinflammatory cytokines provides evidence for a putative role of the vagal cholinergic pathway in NEC pathogenesis. Future studies should focus on application of these techniques to test clinical therapeutics.Video Abstract available at https://journals.lww.com/advancesinneonatalcare/Pages/videogallery.aspx?autoPlay=false&videoId=54.
Copyright © 2021 by The National Association of Neonatal Nurses.
Conflict of interest statement
K.K.D. and C.P. are inventors on a US patent that describes analytic methods used for heart rate variability to determine necrotizing enterocolitis risk. This patent is owned by The Pennsylvania State
References
- Arch Dis Child Fetal Neonatal Ed. 2007 Nov;92(6):F449-53 - PubMed
- Neurogastroenterol Motil. 2009 Jan;21(1):6-17 - PubMed
- BMC Res Notes. 2013 Dec 20;6:547 - PubMed
- Curr Opin Clin Nutr Metab Care. 2015 May;18(3):285-8 - PubMed
- Nature. 2002 Dec 19-26;420(6917):853-9 - PubMed
- J Pediatr. 2016 Jul;174:57-62 - PubMed
- Neurogastroenterol Motil. 2019 Mar;31(3):e13484 - PubMed
- PLoS One. 2013;8(3):e58720 - PubMed
- Adv Neonatal Care. 2012 Apr;12(2):77-87; quiz 88-9 - PubMed
- J Leukoc Biol. 2016 Jan;99(1):67-78 - PubMed
- Adv Neonatal Care. 2018 Feb;18(1):49-57 - PubMed
- J Clin Neonatol. 2014 Jan;3(1):1-9 - PubMed
- Front Psychol. 2017 Feb 20;8:213 - PubMed
- Mediators Inflamm. 2013;2013:434010 - PubMed
- Gastroenterology. 2017 Mar;152(4):730-744 - PubMed
- Pediatrics. 1993 Mar;91(3):617-23 - PubMed
- Front Neurosci. 2018 Feb 07;12:49 - PubMed
- Am J Perinatol. 2017 Nov;34(13):1286-1292 - PubMed
- J Perinat Neonatal Nurs. 2015 Oct-Dec;29(4):315-44; quiz E2 - PubMed
- Clin Perinatol. 2019 Mar;46(1):29-38 - PubMed
- Semin Perinatol. 2008 Apr;32(2):100-6 - PubMed
- Am J Surg. 2015 Oct;210(4):661-7 - PubMed
- Early Hum Dev. 2017 Feb;105:25-33 - PubMed
- Eur J Pharmacol. 2008 Apr 7;583(2-3):174-85 - PubMed
- J Pediatr. 2005 Oct;147(4):462-8 - PubMed
- Eur Heart J. 1996 Mar;17(3):354-81 - PubMed
- Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):590-600 - PubMed
- Pediatr Res. 2014 Jul;76(1):100-8 - PubMed
- J Perinatol. 2017 Jun;37(6):668-672 - PubMed
- Am J Perinatol. 2017 Dec;34(14):1389-1395 - PubMed
- Neurogastroenterol Motil. 2014 Jun;26(6):832-40 - PubMed
- Pediatr Res. 2017 Sep;82(3):438-443 - PubMed
- J Neonatal Nurs. 2017 Jun;23(3):134-141 - PubMed
- J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):51-9; quiz E2 - PubMed
- Natl Vital Stat Rep. 2019 Nov;68(13):1-47 - PubMed
- J Pediatr. 2018 Dec;203:62-67 - PubMed
- Pediatrics. 1995 Nov;96(5 Pt 1):918-22 - PubMed
- Am J Perinatol. 2014 Jun;31(6):489-96 - PubMed
- Pediatrics. 2012 Jun;129(6):1019-26 - PubMed
- BMC Pediatr. 2013 Sep 10;13:138 - PubMed
- Am J Perinatol. 2019 Apr;36(5):505-510 - PubMed
- BMC Pediatr. 2017 Apr 14;17(1):105 - PubMed
- Ann Surg. 1978 Jan;187(1):1-7 - PubMed
- Exp Biol Med (Maywood). 2020 Jan;245(2):85-95 - PubMed
- Am J Perinatol. 2018 Sep;35(11):1079-1086 - PubMed
- Early Hum Dev. 2013 Oct;89 Suppl 2:S13-20 - PubMed
- Curr Pediatr Rev. 2019;15(2):68-87 - PubMed
- Neurogastroenterol Motil. 2019 Nov;31(11):e13682 - PubMed
- Pediatr Crit Care Med. 2016 Apr;17(4):e165-76 - PubMed
Substances
MeSH terms
Publication Types
Grant support